The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach

被引:0
|
作者
Chris De Laet
Anders Odén
Helena Johansson
Olof Johnell
Bengt Jönsson
John A Kanis
机构
[1] Erasmus University Medical Center,Department of Public Health
[2] Erasmus MC,Department of Internal Medicine
[3] Consulting Statistician,Department of Orthopaedics
[4] Malmö General Hospital,WHO Collaborating Centre for Metabolic Bone Diseases
[5] Centre for Health Economics,undefined
[6] University of Sheffield,undefined
来源
Osteoporosis International | 2005年 / 16卷
关键词
Case finding; Fractures; Mathematical model; Osteoporosis; Risk;
D O I
暂无
中图分类号
学科分类号
摘要
The value of bone mineral density (BMD) measurements to stratify fracture probability can be enhanced in a case-finding strategy that combines BMD measurement with independent clinical risk indicators. Putative risk indicators include age and gender, BMI or weight, prior fracture, the use of corticosteroids, and possibly others. The aim of the present study was to develop a mathematical framework to quantify the impact of using combinations of risk indicators with BMD in case finding. Fracture probability can be expressed as a risk gradient, i.e. a relative risk (RR) of fracture per standard deviation (SD) change in BMD. With the addition of other continuous or categorical risk indicators a continuous distribution of risk indicators is obtained that approaches a normal distribution. It is then possible to calculate the risk of individuals compared with the average risk in the population, stratified by age and gender. A risk indicator with a gradient of fracture risk of 2 per SD identified 36% of the population as having a higher than average fracture risk. In individuals so selected, the risk was on average 1.7 times that of the general population. Where, through the combination of several risk indicators, the gradient of risk of the test increased to 4 per SD, a smaller proportion (24%) was identified as having a higher than average risk, but the average risk in this group was 3.1 times that of the population, which is a much better performance. At higher thresholds of risk, similar phenomena were found. We conclude that, whereas the change of the proportion of the population detected to be at high risk is small, the performance of a test is improved when the RR per SD is higher, indicated by the higher average risk in those identified to be at risk. Case-finding strategies that combine clinical risk indicators with BMD have increased efficiency, while having a modest impact on the number of individuals requiring treatment. Therefore, the cost-effectiveness is enhanced.
引用
收藏
页码:313 / 318
页数:5
相关论文
共 46 条
  • [31] Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study
    Pouwels, S.
    van Staa, T. P.
    Egberts, A. C. G.
    Leufkens, H. G. M.
    Cooper, C.
    de Vries, F.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (09) : 1499 - 1506
  • [32] Corticosteroid use and risk of hip fracture: a population-based case-control study in Denmark
    Vestergaard, P
    Olsen, ML
    Johnsen, SP
    Rejnmark, L
    Sorensen, HT
    Mosekilde, L
    JOURNAL OF INTERNAL MEDICINE, 2003, 254 (05) : 486 - 493
  • [33] Strategies to mitigate the impact of COVID-19 on supply chain disruptions: a multiple case analysis of buyers and distributors
    Butt, Atif Saleem
    INTERNATIONAL JOURNAL OF LOGISTICS MANAGEMENT, 2021,
  • [34] Single and combined use of fall-risk-increasing drugs and fracture risk: a population-based case-control study
    Hauff, Jonathan
    Rottenkolber, Marietta
    Oehler, Patrick
    Fischer, Sebastian
    Gensichen, Jochen
    Drey, Michael
    Alexander, G. Caleb
    Guthrie, Bruce
    Dreischulte, Tobias
    AGE AND AGEING, 2023, 52 (06)
  • [35] Use of antiosteoporotic drugs and calcium/vitamin D in patients with fragility fractures: impact on re-fracture and mortality risk
    Luca Degli Esposti
    Anna Girardi
    Stefania Saragoni
    Stefania Sella
    Margherita Andretta
    Maurizio Rossini
    Sandro Giannini
    Endocrine, 2019, 64 : 367 - 377
  • [36] Use of antiosteoporotic drugs and calcium/vitamin D in patients with fragility fractures: impact on re-fracture and mortality risk
    Degli Esposti, Luca
    Girardi, Anna
    Saragoni, Stefania
    Sella, Stefania
    Andretta, Margherita
    Rossini, Maurizio
    Giannini, Sandro
    Vercellone, A.
    Nava, E.
    Ferrante, F.
    Bianchi, C.
    Crescenzi, S.
    Venditti, P. F.
    Folcatrelli, M.
    Constantini, A.
    Cattaruzzi, C.
    ENDOCRINE, 2019, 64 (02) : 367 - 377
  • [37] The impact of Renin-Angiotensin System Inhibitors on bone fracture risk: a nationwide nested case-control study
    Kim, Kwang Min
    Hwang, Eun Jung
    Lee, Sangjin
    Yoon, Jeong-Hyun
    BMC MUSCULOSKELETAL DISORDERS, 2024, 25 (01)
  • [38] Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study
    Pouwels, S.
    Lalmohamed, A.
    Souverein, P.
    Cooper, C.
    Veldt, B. J.
    Leufkens, H. G.
    de Boer, A.
    van Staa, T.
    de Vries, F.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (03) : 903 - 910
  • [39] A population-based case-control study: proton pump inhibition and risk of hip fracture by use of bisphosphonate
    Lee, Joongyub
    Youn, KyungEun
    Choi, Nam-Kyong
    Lee, Jin-Ho
    Kang, DongYoon
    Song, Hong-Ji
    Park, Byung-Joo
    JOURNAL OF GASTROENTEROLOGY, 2013, 48 (09) : 1016 - 1022
  • [40] Using multiple scales of movement to highlight risk-reward strategies of coyotes (Canis latrans) in mixed-use landscapes
    Van Scoyoc, Amy
    Calhoun, Kendall L.
    Brashares, Justin S.
    ECOSPHERE, 2024, 15 (08):